Total results1,200
Search criteria
Number of publications supporting the inclusion of this protein in EV MemProt Atlas.
Annotation confidence score; open for threshold definitions.
Extremely high >= 0.70High >= 0.60Medium >= 0.40Low >= 0.30| UniProt ID | Protein names | Protein classification | Transmembrane count | Related Diseases | Mediation categories | Download | ||||
|---|---|---|---|---|---|---|---|---|---|---|
| HRH1 | P35367 | Histamine H1 receptor (H1-R) (H1R) (HH1R) | FDA approved drug targetsG-protein coupled receptorsPredicted intracellular proteins | 7 | Clinical-translation mediationReceptor-signaling mediation | 6 | 0.63 | |||
| I12R1 | P42701 | Interleukin-12 receptor subunit beta-1 (IL-12 receptor subunit beta-1) (IL-12R subunit beta-1) (IL-12R-beta-1) (IL-12RB1) (IL-12 receptor beta component) (CD antigen CD212) | 1 | Adhesion and uptake mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | ||||
| I17RB | Q9NRM6 | Interleukin-17 receptor B (IL-17 receptor B) (IL-17RB) (Cytokine receptor-like 4) (IL-17 receptor homolog 1) (IL-17Rh1) (IL17Rh1) (Interleukin-17B receptor) (IL-17B receptor) | Predicted membrane proteins | 1 | Immune mediation | 6 | 0.63 | |||
| INSR | P06213 | Insulin receptor (IR) (EC 2.7.10.1) (CD antigen CD220) [Cleaved into: Insulin receptor subunit alpha; Insulin receptor subunit beta] | CD markersDisease related genesEnzymes | 1 | Diabetes mellitusAcute diabetic complicationAlzheimer disease | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| ITB3 | P05106 | Integrin beta-3 (Platelet membrane glycoprotein IIIa) (GPIIIa) (CD antigen CD61) | Cancer-related genesCD markersDisease related genes | 1 | Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediation | 6 | 0.63 | |||
| JAM2 | P57087 | Junctional adhesion molecule B (JAM-B) (Junctional adhesion molecule 2) (JAM-2) (Vascular endothelial junction-associated molecule) (VE-JAM) (CD antigen CD322) | 1 | Fusion and delivery mediationImmune mediation | 6 | 0.63 | ||||
| KCNN2 | Q9H2S1 | Small conductance calcium-activated potassium channel protein 2 (SK2) (SKCa 2) (SKCa2) (KCa2.2) | Disease related genesFDA approved drug targetsHuman disease related genes | 6 | DystoniaIntellectual disabilityMultiple myeloma | Clinical-translation mediationFusion and delivery mediation | 6 | 0.63 | ||
| LAT | O43561 | Linker for activation of T-cells family member 1 (36 kDa phosphotyrosine adapter protein) (pp36) (p36-38) | Disease related genesHuman disease related genesPlasma proteins | 1 | Clinical-translation mediationFusion and delivery mediationImmune mediation | 6 | 0.63 | |||
| NOTC2 | Q04721 | Neurogenic locus notch homolog protein 2 (Notch 2) (hN2) [Cleaved into: Notch 2 extracellular truncation (N2ECD); Notch 2 intracellular domain (N2ICD)] | Cancer-related genesDisease related genesHuman disease related genes | 1 | OsteoporosisLung cancerPancreatic cancer | Clinical-translation mediationImmune mediationReceptor-signaling mediation | 16 | 0.60 | ||
| MFSD1 | Q9H3U5 | Lysosomal dipeptide transporter MFSD1 (Major facilitator superfamily domain-containing protein 1) (Smooth muscle cell-associated protein 4) (SMAP-4) | Predicted intracellular proteinsPredicted membrane proteins | 12 | Fusion and delivery mediation | 13 | 0.60 |